Physician profile
Jack Spitzberg
NPI 1619976966
$2,068.38
in general payments reported to CMS, 2019-2025
18 companies · $34.50 in 2025
The $34.50 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $240 · 2021: $253 · 2022: $331 · 2023: $391 · 2024: $104 · 2025: $34.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $726.72 | 2019-2023 | Repatha |
| Boston Scientific Corporation | $570.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $161.30 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.17 | 2021-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $57.57 | 2022-2023 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $52.77 | 2024 | Arcalyst |
| Astellas Pharma US INC | $46.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $45.66 | 2019-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $42.20 | 2023 | Lutonix Drug Coated Balloon |
| Pfizer INC. | $32.73 | 2022-2024 | |
| Siemens Medical Solutions USA, INC. | $32.17 | 2019 | |
| Itamar Medical INC | $30.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.06 | 2019-2025 | Jardiance |
| Resmed Corp | $22.67 | 2023 | |
| Heartflow, INC. | $17.34 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $17.03 | 2020 | |
| Amarin Pharma, INC. | $16.41 | 2021 | |
| Abbott Laboratories | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Spitzberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.